Mesothelioma Cancer Centers
Cedars-Sinai Medical Center was created by a merger between two longstanding Los Angeles hospitals, Cedars of Lebanon and Mount Sinai. Cedars of Lebanon traces its roots back to 1902, when Kaspare Cohn Hospital — the hospital that would later become Cedars of Lebanon — opened its doors to people in need on the city’s east side. The original hospital was housed in a donated Victorian home in the Angeleno Heights neighborhood; it contained just 12 beds, and its services were free. Early in the hospital’s existence, In 1930 the hospital was renamed “Cedars of Lebanon” after the Lebanon Cedar, a religiously significant tree that was used to build King Solomon’s Temple of Jerusalem in the Bible. Mount Sinai got its start in 1918 as the Bikur Cholim Society, a two-room hospice founded to deal with the Great Influenza Pandemic; a few years later, the hospice was renamed Mount Sinai Home for the Incurables.
Today, Cedars-Sinai has evolved into the largest nonprofit hospital in the western United States. It’s also highly respected: For the past two decades the hospital has been consistently recognized by the National Research Corporation as southern California’s “gold” standard in health care.
The Lung Cancer Program at Cedars-Sinai Medical Center takes a multidisciplinary approach to treating mesothelioma cancer. Their team, which includes experts across a variety of specialties, work quickly to make the time between diagnosis and treatment as short as possible for better patient outcomes.
The center uses chest X-rays and advanced CT lung screening to determine mesothelioma diagnosis. A biopsy will also be performed to better understand the stage of cancer. The team analyzes the results together to find the best treatment methods possible for a patient’s individual mesothelioma diagnosis. Advanced cases may require multimodal treatment, which typically includes chemotherapy, radiation and may include surgery in some cases. The team specializes in minimally invasive surgeries and video-assisted surgeries to make hospital stay times shorter and to minimize pain for the patient.
The Lung Cancer Program provides patients with a patient navigator, who will act as their liaison for appointments and carefully consider the patient’s needs and physician recommendations. They also allow patients to enroll in clinical trials when applicable, and often offer clinical trials as a pathway for treatment in order for patients to receive advanced and emerging treatment that they may not be able to access at other centers.
- Minimally invasive surgery
- Video-assisted thoracoscopic surgery (VATS)
- Wedge resection and brachytherapy
- CT-guided radiofrequency ablation
- Open surgery
- Endoscopic laser therapy
- Ranked No. 41 for cancer hospitals by U.S. News & World Report
- Top 10 physician groups in Southern California by Integrated Health Care Associates (IHA)
Mesothelioma Clinical Trials at Cedars-Sinai Medical Center
The following clinical trials are in progress or actively recruiting participants at Cedars-Sinai Medical Center:
Conditions: Melanoma; Breast Carcinoma; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Non-small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Endometrial Carcinoma; Mesothelioma; Neuroendocrine Carcinoma; Cervical Cancer; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of the Anus Last Updated: April 29, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette